Literature DB >> 7248040

Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist.

D C Warltier, C M Meils, G J Gross, H L Brooks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7248040

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  20 in total

1.  Vasodilatory effects of nisoldipine on coronary arteries--correlation with plasma levels.

Authors:  S Jost; W Rafflenbeul; B Mogwitz; D Gulba; H Hecker; P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

Review 2.  Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  H A Friedel; E M Sorkin
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

3.  Transmural gradient of coronary blood flow following dihydropyridine calcium antagonists and other vasodilator drugs.

Authors:  D C Warltier; H F Hardman; H L Brooks; G J Gross
Journal:  Basic Res Cardiol       Date:  1983 Nov-Dec       Impact factor: 17.165

Review 4.  Diltiazem.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-01

Review 5.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 6.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

7.  The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.

Authors:  F Pasanisi; P A Meredith; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Importance of myocardial blood flow changes in the protective action of diltiazem in a new model of myocardial ischaemia.

Authors:  L Szekeres; E Udvary; A Végh
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

9.  Nisoldipine tablets once daily versus nifedipine capsules three times daily in patients with stable effort angina pectoris pretreated with atenolol.

Authors:  T R Pedersen; M Kantor
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

10.  The haemodynamic actions of ZENECA ZD7288, a novel sino-atrial node function modulator, in the exercising beagle: a comparison with zatebradine and propranolol.

Authors:  W Rouse; P J Stafford; I R Johnson
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.